Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Катадолон® в лечении болевых синдромов
Катадолон® в лечении болевых синдромов
Л.И.Алексеева, Е.А.Таскина. Катадолон® в лечении болевых синдромов. Consilium Medicum. Неврология (Прил.). 2011; 2: 10-14.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Classification of chronic pain: descriptions of chronic pain and syndromes of definition of terms. Eds. H.M.Merskey, N.Bogduk. 2nd ed. Seattle: IASP Prerss, 1994.
2. Патофизиология. Курс лекций: учебное пособие. Под ред. П.Ф.Литвицкого. М.,1995.
3. Soldato M, Liperoti R, Randi F et al. Non malignant daily pain and risk of disability among older adults in home care in Europe. Pain 2007; 129 (3): 304–10.
4. Болевые синдромы в неврологической практике. Под ред. А.М.Вейна. М., 2001.
5. ACPA Medications and Chronic Pain Supplement 2007 American Chronic Association. P.O. Box 850. Rocklin CA 95677.
6. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms/prepared by International Association for the Study of Pain, Task Force on Taxonomy. Eds. H.Merskey, N.Bogduk. 2nd ed. Seattle: IASP Press, 1994.
7. Гехт М.Б. Мышечные спазмы и боль. Материалы 1-й конференции Российской ассоциации по изучению боли. М., 1993.
8. Scheef W. Analgesic efficacy and safety of oral flupirtine in the treatment of cancer pain. Postgrad Med J 1987; 63: 67–70.
9. Million R, Finlay BR, Whittington JR. Clinical trial of flupirtine maleate in patients with migraine. Curr Med Res Opin 1984; 9: 204–12.
10. Mastronardi P, D'Onofrio M, Scanni E et al. Analgesic activity of flupirtine maleate: a controlled double-blind study with diclofenac sodium in orthopaedics. J Int Med Res 1988; 16: 338–48.
11. Riethmuller-Winzen H. Flupirtine in the treatment of post-operative pain. Postgrad Med J 1987; 63: 61–6.
12. Luben V, Muller H, Lobisch M, Worz R. Treatment of cancer pain with flupirtine. Results of double-blind study versus tramadol. Fortschr Med 1994: 112 (19); 31–8.
13. Goodchild CS, Nelson J, Cooke I et al. Combination therapy with flupirtine and opioid: open-label case series in the treatment of neuropathic pain associated with cancer. Pain Med 2008; 9 (7): 939–49.
14. McMahon G, Arndt W, Newton J, Montgomery P. Clinical experience of flupirtine in the US. Postgrad Med J 1987; 63: 81–5.
15. Weiser T, Szelenyi I, Nickel B, Weinrich M. In vitro and in vivo findings about the muscle relaxing properties of flupirine. Naunyn-Schmiedeberg’s Arch. Pharmacol 1992; 246 (Suppl. 1): 22.
16. Worz R et al. Flupirtine in comparison with chlomiezanont in chronic musculoskeletal back pain. Results of a multicenter randomized double-blind study. Fortschr Med 1996: 114 (3636); 500–4.
17. Mueller-Schwefe G. Flupirtine in acute and chronic pain associated with muscle tenseness. Results of a postmarket surveillance study. Fortschr Med Orig 2003; 121 (1): 11–6.
18. European Guidelines For the Management Of Acute Nonspecific Low Back Pain Tn Primary Care, 2004.
19. Worz R, Mueller-Schwefe G, Stroehmann I et al. Back pain: Guidelines for drug therapy Fortschr Med 2000; 142 (5): 27.
20. Ringe JD, Miethe D, Pittrow D, Wegscheider K. Analgesic efficacy of flupirtine in primary care of patients with osteoporosis related pain. A multivariate analysis. Arzneimittelforschung 2003; 53 (7): 496–502.
21. Perovich S, Schleger C, Pergande G et al. The triaminopyridine flupirtine prevents cell death in rat cortical cells induced by NMDA and gpl20. Eur J Pharmacol Mol Pharmacol Sect 1994; 288: 27–33.
22. Ruppala K, Cao W, Kriegelstein J. Flupirtine protects neurones against ischemic and excitotoxic damage and inhibits the increase ocytosolic Ca2+ concentration. Eur J Pharmacol 1995; 294: 469–73.
23. Schwarz M, Schmitt T, Pergande G, Block M. N-Methyl-d-aspartate and a2-adrenergic machanisms are involved in the depressent action of flupirtine on spinal reflexes in rats. Eur J Pharmacol 1995; 276: 247–55.
24. Sheridan PH, Seaman CA, Narang PK et al. Pilot study of flupirtini in refractery seizures. Neurology 1986; 36 (Suppl. 1): 85.
25. Gassen M, Pergande G, Youdim ВH. Antioxidant properties of the triaminopyridine, flupirtine. Biochemical Pharmacol 1998; 56 (10): 1323–9.
26. Herrmann WM, Kern U, Aigner M. On the adverse reactions and efficacy of long-term treatment with flupirtine: preliminary results of an ongoing twelve-month study with 200 patients suffering from chronic pain states in arthrosis or arthritis. Postgrad Med J 1987; 63: 87–103.
27. Herrmann WM, Hiersemenzel R, Aigner M et al. Long-term tolerability of Flupirtine. Fortschritte der Medizin 1993; 111 (15): 3–13.
2. Патофизиология. Курс лекций: учебное пособие. Под ред. П.Ф.Литвицкого. М.,1995.
3. Soldato M, Liperoti R, Randi F et al. Non malignant daily pain and risk of disability among older adults in home care in Europe. Pain 2007; 129 (3): 304–10.
4. Болевые синдромы в неврологической практике. Под ред. А.М.Вейна. М., 2001.
5. ACPA Medications and Chronic Pain Supplement 2007 American Chronic Association. P.O. Box 850. Rocklin CA 95677.
6. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms/prepared by International Association for the Study of Pain, Task Force on Taxonomy. Eds. H.Merskey, N.Bogduk. 2nd ed. Seattle: IASP Press, 1994.
7. Гехт М.Б. Мышечные спазмы и боль. Материалы 1-й конференции Российской ассоциации по изучению боли. М., 1993.
8. Scheef W. Analgesic efficacy and safety of oral flupirtine in the treatment of cancer pain. Postgrad Med J 1987; 63: 67–70.
9. Million R, Finlay BR, Whittington JR. Clinical trial of flupirtine maleate in patients with migraine. Curr Med Res Opin 1984; 9: 204–12.
10. Mastronardi P, D'Onofrio M, Scanni E et al. Analgesic activity of flupirtine maleate: a controlled double-blind study with diclofenac sodium in orthopaedics. J Int Med Res 1988; 16: 338–48.
11. Riethmuller-Winzen H. Flupirtine in the treatment of post-operative pain. Postgrad Med J 1987; 63: 61–6.
12. Luben V, Muller H, Lobisch M, Worz R. Treatment of cancer pain with flupirtine. Results of double-blind study versus tramadol. Fortschr Med 1994: 112 (19); 31–8.
13. Goodchild CS, Nelson J, Cooke I et al. Combination therapy with flupirtine and opioid: open-label case series in the treatment of neuropathic pain associated with cancer. Pain Med 2008; 9 (7): 939–49.
14. McMahon G, Arndt W, Newton J, Montgomery P. Clinical experience of flupirtine in the US. Postgrad Med J 1987; 63: 81–5.
15. Weiser T, Szelenyi I, Nickel B, Weinrich M. In vitro and in vivo findings about the muscle relaxing properties of flupirine. Naunyn-Schmiedeberg’s Arch. Pharmacol 1992; 246 (Suppl. 1): 22.
16. Worz R et al. Flupirtine in comparison with chlomiezanont in chronic musculoskeletal back pain. Results of a multicenter randomized double-blind study. Fortschr Med 1996: 114 (3636); 500–4.
17. Mueller-Schwefe G. Flupirtine in acute and chronic pain associated with muscle tenseness. Results of a postmarket surveillance study. Fortschr Med Orig 2003; 121 (1): 11–6.
18. European Guidelines For the Management Of Acute Nonspecific Low Back Pain Tn Primary Care, 2004.
19. Worz R, Mueller-Schwefe G, Stroehmann I et al. Back pain: Guidelines for drug therapy Fortschr Med 2000; 142 (5): 27.
20. Ringe JD, Miethe D, Pittrow D, Wegscheider K. Analgesic efficacy of flupirtine in primary care of patients with osteoporosis related pain. A multivariate analysis. Arzneimittelforschung 2003; 53 (7): 496–502.
21. Perovich S, Schleger C, Pergande G et al. The triaminopyridine flupirtine prevents cell death in rat cortical cells induced by NMDA and gpl20. Eur J Pharmacol Mol Pharmacol Sect 1994; 288: 27–33.
22. Ruppala K, Cao W, Kriegelstein J. Flupirtine protects neurones against ischemic and excitotoxic damage and inhibits the increase ocytosolic Ca2+ concentration. Eur J Pharmacol 1995; 294: 469–73.
23. Schwarz M, Schmitt T, Pergande G, Block M. N-Methyl-d-aspartate and a2-adrenergic machanisms are involved in the depressent action of flupirtine on spinal reflexes in rats. Eur J Pharmacol 1995; 276: 247–55.
24. Sheridan PH, Seaman CA, Narang PK et al. Pilot study of flupirtini in refractery seizures. Neurology 1986; 36 (Suppl. 1): 85.
25. Gassen M, Pergande G, Youdim ВH. Antioxidant properties of the triaminopyridine, flupirtine. Biochemical Pharmacol 1998; 56 (10): 1323–9.
26. Herrmann WM, Kern U, Aigner M. On the adverse reactions and efficacy of long-term treatment with flupirtine: preliminary results of an ongoing twelve-month study with 200 patients suffering from chronic pain states in arthrosis or arthritis. Postgrad Med J 1987; 63: 87–103.
27. Herrmann WM, Hiersemenzel R, Aigner M et al. Long-term tolerability of Flupirtine. Fortschritte der Medizin 1993; 111 (15): 3–13.
Авторы
Л.И.Алексеева, Е.А.Таскина
НИИ ревматологии РАМН, Москва
НИИ ревматологии РАМН, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.